D-1428-2012 Class II Terminated
FDA drug recall D-1428-2012 was initiated by Zydus Pharmaceuticals USA Inc on Mar 14, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving… The recall status is terminated (terminated Dec 17, 2013). Affected quantity: 1176 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 8, 2012
- Initiation Date
- Mar 14, 2012
- Termination Date
- Dec 17, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1176 Bottles
Product description
Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.
Reason for recall
Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.
Distribution pattern
Nationwide
Code information
Lot #: ML9605 Exp. 10/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1428-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026